Palantir Grew 85% and the Market Sold It Off
Monetary Elite PLTR beat on every line in Q1 2026. The stock dropped anyway. Here's what that tension actually means.
NVDA After the Beat: Why the Options Market Didn’t Celebrate
Record revenue. Record guidance. And the stock still drifted lower. Here's what that tells options traders right now.
The Defense Trade Is Not What You Think — Here’s How to Actually Position It
Between Iran ceasefire signals, record backlogs, and Palantir's 85% revenue surge, the defense sector just got a lot more complicated.
NVDA, ARM, AMD: The AI Chip Supercycle Just Printed Its Loudest Number Yet
NVIDIA's Q1 FY2027 earnings crushed expectations – and the options market is still digesting what it means.
The Energy Trade Just Got Complicated — Here’s What the Numbers Are Actually Telling You
XLE posted a 37% Q1 surge. But with Brent near $106, a Strait of Hormuz standstill, and the EIA flagging…
LLY and the GLP-1 Franchise: What the Options Market Knows That the Headlines Don’t
Eli Lilly's Q1 blowout reset the ceiling — and the options flow is telling a very specific story
Rigetti Computing (RGTI): The Quantum Stock the Government Just Bet $100 Million On
A landmark CHIPS Act deal and a commercial hardware breakthrough are changing the conversation around this volatile pure-play.
Eli Lilly (LLY): The GLP-1 Trade Is Bigger Than the Market Thinks
Mounjaro up 125%. Zepbound up 79%. A new oral pill just launched. The growth story keeps widening.
The War Nobody Expected Handed Energy Its Best Year in a Decade
Occidental Petroleum is at the center of a commodity supercycle that Wall Street is still underestimating
MercadoLibre (MELI): The Latin American Powerhouse Trading Like It’s in Trouble
49% revenue growth, a doubling credit card portfolio, and a stock down nearly 40% from its highs. Something doesn't add…